APA (7th ed.) Citation

Harder, J., Hofheinz, R., & Büchler, P. (2012). Multicentre phase II trial of trastuzumab and capecitabine in patients with HER2 overexpressing metastatic pancreatic cancer. British journal of cancer, 106(6), . https://doi.org/10.1038/bjc.2012.18

Chicago Style (17th ed.) Citation

Harder, Jan, Ralf-Dieter Hofheinz, and Peter Büchler. "Multicentre Phase II Trial of Trastuzumab and Capecitabine in Patients with HER2 Overexpressing Metastatic Pancreatic Cancer." British Journal of Cancer 106, no. 6 (2012). https://doi.org/10.1038/bjc.2012.18.

MLA (9th ed.) Citation

Harder, Jan, et al. "Multicentre Phase II Trial of Trastuzumab and Capecitabine in Patients with HER2 Overexpressing Metastatic Pancreatic Cancer." British Journal of Cancer, vol. 106, no. 6, 2012, https://doi.org/10.1038/bjc.2012.18.